Sartorius Aktiengesellschaft (SRT.F)
- Previous Close
225.00 - Open
216.00 - Bid 224.50 x 6000
- Ask 230.00 x 5000
- Day's Range
216.00 - 216.00 - 52 Week Range
182.60 - 310.00 - Volume
10 - Avg. Volume
28 - Market Cap (intraday)
17.693B - Beta (5Y Monthly) 0.84
- PE Ratio (TTM)
100.00 - EPS (TTM)
2.16 - Earnings Date Jul 19, 2024
- Forward Dividend & Yield 0.73 (0.34%)
- Ex-Dividend Date Apr 2, 2024
- 1y Target Est
109.00
Sartorius Aktiengesellschaft provides bioprocess solutions and lab products and services in the United States and internationally. The company offers multi-parallel, benchtop, single-use, stainless steel, cell culture, rocking motion, and microbial bioreactors, and software apps for bioreactors and cell culture shake flask; fermenters; cell culture media products; cellcelector flex, incubator flowbox, nanowell arrays, and capillaries and tips; fluid management products; microbiology products; and Ultrafiltration membrane filters, glass and quartz microfiber filters, clarification, syringeless and in-line filters, lab chromatography, and filters and blotting papers. It also provides live-cell analysis systems, reagents and consumables, support and services, and live-cell imaging and analysis software; contract manufacturing and integration, membranes and devices, weigh cells, and data analytics, as well as connectivity, and pipetting and dispensing modules; electronic and mechanical pipettes, pipette tips, bottle-top dispensers, and pipette controllers and accessories; process automation platform and software, sensors and analyzers, biomolecule analysis tools, and data analytics software; chromatography consumables, columns, and systems; and biolayer interferometry products. In addition, the company offers water purification systems; surface plasmon resonance; lab balances, pipette calibration, mass comparators and metrology, moisture analyzers, equipment manufacturer cells, weights and weight sets, paint mixing solutions, and weighing accessories; and process filtration. Further, the company provides bioprocess consulting and engineering, biologics testing, media and process, instrument, octet service and support, and validation services. It serves the life science research, biopharmaceutical manufacturing, pharmaceutical quality control, cell and gene therapy, and applied industries. Sartorius Aktiengesellschaft was founded in 1870 and is headquartered in Göttingen, Germany.
www.sartorius.com14,614
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: SRT.F
Performance Overview: SRT.F
Trailing total returns as of 4/26/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SRT.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SRT.F
Valuation Measures
Market Cap
17.69B
Enterprise Value
21.75B
Trailing P/E
100.00
Forward P/E
47.17
PEG Ratio (5yr expected)
2.07
Price/Sales (ttm)
2.24
Price/Book (mrq)
5.53
Enterprise Value/Revenue
6.57
Enterprise Value/EBITDA
26.01
Financial Highlights
Profitability and Income Statement
Profit Margin
4.49%
Return on Assets (ttm)
3.44%
Return on Equity (ttm)
6.98%
Revenue (ttm)
3.31B
Net Income Avi to Common (ttm)
148.8M
Diluted EPS (ttm)
2.16
Balance Sheet and Cash Flow
Total Cash (mrq)
1.1B
Total Debt/Equity (mrq)
138.33%
Levered Free Cash Flow (ttm)
-84.19M
Research Analysis: SRT.F
Company Insights: SRT.F
SRT.F does not have Company Insights